loading

Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.87%
83.34
84.07 81.80 73.46 76.21
Cost Of Revenue
4.52%
50.75
48.56 47.37 45.12 44.37
Gross Profit
8.25%
32.58
35.51 34.44 28.35 31.85
Operating Expenses
35.31%
68.82
50.86 54.15 48.14 47.98
Benefits Costs and Expenses
22.97%
112.61
91.58 103.32 85.19 84.26
Costs And Expenses
22.97%
112.61
91.58 103.32 85.19 84.26
Operating Income/Loss
136.08%
-36.24
-15.35 -19.71 -19.80 -16.14
Nonoperating Income/Loss
11.18%
6.964
7.841 -1.806 8.072 8.09
Income/Loss From Continuing Operations Before Tax
289.85%
-29.27
-7.509 -21.52 -11.72 -8.045
Income Tax Expense/Benefit, Deferred
87.96%
-0.104
-0.864 -0.113 -0.133 -0.364
Income Tax Expense/Benefit
723.43%
-5.624
-0.683 -2.263 0.176 -1.855
Income/Loss From Continuing Operations After Tax
246.47%
-23.65
-6.826 -19.26 -11.90 -6.19
Net Income/Loss
246.47%
-23.65
-6.826 -19.26 -11.90 -6.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
6.42%
-0.232
-0.218 -0.299 -0.369 -0.302
Basic Average Shares
99.78%
0.069
30.75 30.54 30.83 0.14
Diluted Average Shares
99.78%
0.069
30.75 30.54 30.83 0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research LH
$263.80
price up icon 0.34%
diagnostics_research DGX
$199.70
price down icon 0.59%
diagnostics_research MTD
$1,173.74
price up icon 0.49%
$187.85
price down icon 1.29%
diagnostics_research IQV
$164.72
price up icon 1.10%
diagnostics_research WAT
$286.57
price up icon 1.15%
Capitalizzazione:     |  Volume (24 ore):